- New Roadmap RFA Co-led by NIDA and OBSSR:
Facilitating Interdisciplinary Research Via Methodological and Technological Innovation in the Behavioral and Social Sciences (R21)
Letters of Intent Receipt Date(s): January 23, 2007
Application Submission/Receipt Date(s): February 23, 2007
A new NIH Roadmap Funding Opportunity Announcement (FOA) has been released entitled, "Facilitating Interdisciplinary Research via Methodological and Technological Innovation in the Behavioral and Social Sciences." As an initiative that was developed to support interdisciplinary "Research Teams of the Future," this Request for Applications (RFA) reflects the goals the NIH Roadmap, and is sponsored by multiple NIH Institutes. This RFA, using a modified Exploratory/Developmental (R21) mechanism, solicits applications to develop new/innovative measures, methods, and technologies that support the interdisciplinary integration of human social and/or behavioral science with other disciplines across varying levels of analysis.
NIDA and OBSSR have worked as co-leads with their Project Team to prepare this RFA and NIDA will administer funded grant projects on behalf of the NIH for this Roadmap Initiative.
- NIH Director's Pioneer Award Program (DP1)
Application Receipt Date: January 16, 2007
- The Solicitation of Assays for High Throughput Screening in the Molecular Libraries Screening Centers Network (MLSCN) (R03)
Application Receipt Dates: Feb 26, 2007; Jun 26, 2007 and Oct 26, 2007
- The Solicitation of Assays for High Throughput Screening in the Molecular Libraries Screening Centers Network (X01)
Application Receipt Dates: Jan 18, 2007; May 18, 2007 and Sep 14, 2007
- Interdisciplinary Research Consortium (U54)
Application Receipt Dates(s): December 19, 2006
- Institutional Clinical and Translational Science Award (CTSA) (U54)
Application Receipt Date: January 17, 2007
NIDA Symposium: The NIH Roadmap: Inviting Drug Abuse and Addiction Researchers to Contribute to the Clinical Research Enterprise
The NIH Roadmap is a series of progressive initiatives that seek to transform the nation's biomedical research capabilities and accelerate the advancement of research discoveries from the bench to the bedside. All Institutes, including NIDA, are involved in this endeavor.
The Roadmap is composed of three overarching themes: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. All three of these broad initiatives have current and future funding opportunities associated with them, which NIDA grantees can apply.
The NIH Roadmap provides an extraordinary opportunity for drug abuse and addiction researchers to take advantage of new NIH funding mechanisms and to become an integral part of transforming how we approach diseases, like addiction, in this country. I hope that you will review the NIH Roadmap funding opportunities listed above. If you have any questions, you are encouraged to contact your program officer or the contact person listed in the links above. For more on the NIH Roadmap for Medical Research, see http://nihroadmap.nih.gov/.
578255 since 12/23/03